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responsibility of XAbstract A novel chemiluminescence (CL) reaction was based on the oxidizing reaction of luminol
by the trivalent copper-periodate complex (K5[Cu(HIO6)2], DPC) in alkaline medium. The CL
intensity could be enhanced in the presence of amikacin sulfate (AKS). A new CL method was
developed for the determination of AKS by coupling with ﬂow injection (FI) technology. Because
of the distinctive oxidative effect of DPC, the luminol-based CL reaction could occur at a low
concentration of 107 M. The relative CL intensity was proportional to the concentration of AKS
in the range of 4.0 109–4.0 106 g/mL with the detection limit of 1.2 109 g/mL. The relative
standard deviation was 2.1% for 8.0 109 g/mL AKS (n¼9). The proposed method was
successfully applied to the direct determination of AKS at the level of ng/mL in serum samples.
The recovery varied from 97.0% to 106.3%. A possible mechanism of the CL reaction was
discussed in detail by relating to the CL kinetic characteristics and electrochemical activities of the
oxidant DPC.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.ersity. Production and hosting by E
.011
84110922;
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i’an Jiaotong University.1. Introduction
Amikacin(O-3-amino-3-desoxy-a-d-glucopyranosyl-(1-6)-O-[6-
amino-6-desoxy-a-d-glucoyra-nosyl-(1-4)]-N1-(4-amino-2-hydro-
xy-1-oxobutyl)-2-desoxy-d-streptamine, C22H43N5O13) sulfate is
one of the most broad-spectrum aminoglycoside antibiotics [1,2].
As its structure is shown in Scheme 1, it has the characteristics of
being semi-synthetic and water soluble. It can curb drug
resistance to gentamicin, kanamycin and tobramycin because
of its fewer points susceptible to enzymatic attack than the otherlsevier B.V. All rights reserved.
Scheme 1 Structure of amikacin sulfate.
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also lead to ototoxicity and nephrotoxicity. Therefore, it is
important to monitor the concentration level of amikacin in
plasma during the process of therapeutic and toxic control. It is
essential to develop a simple, sensitive and speciﬁc method for
trace analysis of amikacin sulfate (AKS) in plasma. Methods
have been reported for the determination of AKS, including
atomic absorption spectrometry [3], spectrophotometric method
[4], ﬂuorescence method [5,6], chemiluminescence method [7],
thin-layer chromatography [8], liquid chromatography [9–11],
voltammetry [12] and capillary electrophoresis [13]. However,
due to the structural characteristics of AKS, a special pretreat-
ment step (such as derivatization) is needed. Some of the
methods mentioned above require special instruments (such as
ﬂourescence or HPLC); some are not sensitive enough to
determine AKS in real samples. The goal of the present work
was to develop a direct and sensitive method for the determina-
tion of AKS in serum samples.
Chemiluminescence (CL) is known to be a widely-used
analytical method for its higher sensitivity, lower detection
limit and wider linear range with a simpler instrument [14]. As
a highly sensitive detection tool, CL has gained an increasing
attention in considerable ﬁelds such as clinical, pharmaceu-
tical, environmental and food analyses [15]. The oxidation of
luminol (3-aminophthalhydrazide) in alkaline medium is one
of the most efﬁcient CL reactions and has been widely used in
the quantitative analysis of many inorganic and organic
compounds [16]. These luminol-based CL system needs some
oxidants such as hydrogen peroxide, oxygen, potassium
permanganate, ferricyanide, periodate and oxygen free radi-
cals [17–23]. Since then, there has been a continuing interest in
the development of novel oxidant reagents for the luminol-
based CL reaction, which can widen the application of the
luminal-based CL reaction. As valid oxidant reagents, the
transition metals in uncommon oxidation state such as Ag
(III) and Cu (III) have been reported in recently years. They
can be stabilized by the chelation with suitable polydentate
ligands [24,25]. The related studies mainly focus on the
kinetics and mechanism of oxidant reactions [26,27]. The
diperiodatocuprate (III) (K5[Cu(HIO6)2], DPC) [28] is a
relatively weak oxidizing agent in alkaline medium with the
reduction potential of 0.42 V (Vs SCE) [29]. In our previous
work, the H2O2 determination method has been proposed for
the catalytic effect of Cu (III) complex [30].
We found that the novel CL was based on the oxidizing
reaction of luminol and the trivalent copper-periodate com-
plex (K5[Cu(HIO6)2], DPC) in alkaline medium. The CL
intensity could be enhanced in the presence of AKS. DPC
was obtained by complexation of trivalent copper and period-
ate in strong alkaline medium. The luminol-based oxidant
reaction could occur at a lower concentration of 107 M,which gave the CL system the characteristic of being selective.
The enhanced light emission caused by AKS could be used for
the quantitative analysis of AKS concentration in serum
samples. A novel, more sensitive and selective chemilumines-
cence method was developed for trace analysis of AKS in
serum by coupling ﬂow injection analysis (FIA) techniques
without any pretreatment of samples. Based on the electro-
chemical reaction and kinetics curve of the CL reaction
experiment, the mechanism of the reaction was also discussed.2. Experimental
2.1. Reagents and chemicals
Luminol (5-amino-2,3-dihydro-1,4-phthalazinedione) was kindly
provided by Shaanxi Normal University (Xi’an, China). The
standard medicine of AKS was obtained from Chongqing
Institute for Drug Control (Chongqing, China). It was dissolved
to prepare the stock solution with the concentration of 1 104 g/
mL with distilled water. It was stored at 4 1C and diluted to
working solution with distilled water. The reagents for DPC
preparation were listed as follows: Potassium persulfate (Na2S2O8)
was purchased from Shanghai Aijian Chemical Reagent Company
(Shanghai, China), cupric sulfate (CuSO4  5H2O) and potassium
hydroxide (KOH) were purchased from Chongqing Chemical
Reagent Company (Chongqing, China), and potassium periodate
(KIO4) was purchased from Shanghai Chemical Reagent Com-
pany (Shanghai, China). All of the chemicals were of analytical
reagent grade and used without further puriﬁcation. Doubly
distilled water was used throughout the work. The diluted working
solutions were prepared and used freshly and daily. A luminol
stock solution (0.01 M) was prepared by dissolving 1.772 g
luminol in 1 L carbonate buffer (0.1 M), and left to stand for
approximately 24 h before use. The luminol solution was stable
for at least 1 month when stored in the dark. The DPC stock
solution (0.01 M) was prepared by oxidizing Cu (II) in the alkaline
medium according to the known method [28]. In brieﬂy, KIO4
(0.23 g), CuSO4  5H2O (0.125 g), Na2S2O8 (0.14 g) and KOH
(0.8 g) were added into 30 mL water. The mixture was heated to
boil for about 20 min on a hot plate with constant stirring. After
the boiling mixture turned intensely red, the boiling continued for
another 20 min for the completion of the synthetic reaction. When
the mixture was cooled, it was diluted to 50 mL with distilled
water. The stock solution obtained was refrigerated at 4 1C, which
was found fairly stable for several months, and DPC solutions
were freshly prepared before use. The complex was conﬁrmed at
415 nm by UV/Visible spectrum with the molar absorptive (e) of
62307100 L3/mol cm.
2.2. Apparatus
The schematic diagram of the used FIA-CL system in this
work is shown in Fig. 1. All the chemicals were delivered to
the system with two peristaltic pumps (HL-2, Shanghai Huxi,
China) at a ﬂow rate of 2 mL/min. The polytetraﬂuorothylene
(PTFE) ﬂow tubes (0.8 mm i.d.) were used to connect all the
components in the system. A sixteen-port injection valve
(Hanzhou, China) was equipped with a loop of 75 mL which
was used to process the injection mode. The CL signal was
monitored by a BPCL ultra-weak luminescence analyzer
(Institute of Biophysics, Chinese Academy of Sciences, Beijing,
Y.-F. Hu et al.362China) which consists of a ﬂat coil glass ﬂow cell facing the
window of the photomultiplier tube (PMT). Data were acquired
and processed with BPCL software running under Windows 98.
The UV-Vis-2001 spectrophotometer (Hitachi Ltd., Japan) was
used for UV-absorbance detection. The CL spectrum was
obtained with the LS45/55 ﬂuorospectrophotometer (PerkinEl-
mer Ltd. America). The electrochemical characteristics of
copper metal chelate complex were studied using the CHI832
electrochemical workstation (ChenHua Ltd., Shanghai, China).Fig. 2 Kinetics curves of luminol-DPC catalyzed by samples.
Luminol solution, 1 107 M; DPC solution, 4 104 M; injected
AKS solution, 2 107 g/mL.2.3. Procedure
As shown in Fig. 1, the ﬂow lines were inserted into the
luminol solution, an analyte (a standard AKS solution or a
sample containing AKS, respectively) and DPC solutions. The
peristaltic pumps were started to wash the whole system at
2.0 mL/min, and then the in-line and real-time determination
models were performed by inserting the ﬂow line ‘‘b’’ into the
vessel containing the collected samples. When the injection
valve was set to the load position, the stream of DPC solution
and luminol solution was mixed at ‘‘M’’ point, and then the
whole system was run until a stable baseline was recorded.
When the injection valve was switched to the inject position,
the carrier stream DPC solution bypassed the reagent loop
(75 mL analyte solution) and ran directly through the ﬂow cell,
producing CL emission. The CL signal was then recorded
simultaneously. Under the PMT operated at 800 V, the
relative CL intensity DI, deﬁned as the difference of CL
intensity between in the presence and in the absence of analyte
respectively, was proportional to the corresponding concen-
tration of AKS solution.3. Results and discussion
3.1. Kinetics curve of the CL reaction of luminol -DPC-AKS
In the batch mode, with the experimental parameters kept
constant, the typical response curve (intensity versus times) of
the CL reaction between luminol solution (1 107M) and
DPC (4 104M) in the presence of ASK solution with the
concentration of 2 107 g/mL was recorded to study the
kinetic characteristics of the CL reaction. As shown in Fig. 2,
the CL intensity peak appeared within 1 s after AKS was
injected into the mixture solution of luminol and DPC. The
CL signals would decrease to the baseline within 10 s. Fig. 2Fig. 1 Schematic diagram of the CL-FIA system. P: peristaltic
pump; V: injection valve; M: mixtured Position; F: spiral glass
ﬂow cell; PMT: photomultiplier tube; W: waste; H: light tight
house; PC: personal computer. (a) luminol solution; (b) analyte
solution; (c) DPC solution.shows that the CL intensity of luminol-DPC could be greatly
enhanced by the AKS solution. The CL reaction was
obviously quick. The kinetics curve indicated the CL system
was rapid and sensitive enough and suitable for the analysis
of AKS.
3.2. Optimization of the experiment procedure
As is well-known, luminol is one of the most popular CL
reagents for its oxidation in alkaline medium. These luminol-
based CL reactions mainly result from the oxidant reaction of
luminol with a range of typical oxidants, such as oxygen,
hydrogen peroxide, potassium permanganate, ferricyanide,
tetravalent cerium ion, lead dioxide and oxygen free radicals.
The oxidant reaction of luminol with these typical oxidants
can occur when the concentration of luminol is up to
1 105 M. The difference of DPC from these typical oxi-
dants enabled the emitted luminal-based CL signal to be
clearly observed when luminol was lower than 1.0 106 M.
So the effect of luminol concentration was examined over the
range from 1 108 M to 5 107 M when the DPC and
AKS solutions were ﬁxed at a certain concentration. As shown
in Fig. 3, the CL intensity increased with an increase of the
luminol concentration in the presented range. For avoidance
of PMT saturation and minimal reagent consumption were
considered, the optimal concentration of luminol was
1 107 M for the subsequent experiment. The use of luminol
with a lower concentration also effectively avoided the inter-
ference by other common oxidants.
The kinetics test showed that the luminol-based CL was
based on the oxidation reaction with DPC and enhanced by
AKS. To test the effect of DPC solution, a range of
concentrations of DPC (1 105 M–1 103 M) was investi-
gated. As the result in Fig. 4 showed, the CL intensity was
increased with the increase of the DPC concentration in a low-
concentration range (4 104 M), and reached the maximum.
Above 4 104 M, the CL intensity decreased probably because a
higher concentration of DPC caused self-absorption. Therefore,
the optimal concentration was 4 104 M.
Generally, the CL oxidation of luminol by oxidants often
occurs in basic conditions. Additional DPC was obtained in
strong alkaline solution (KOH solution). A solution of KOH
Fig. 3 The effect of the luminol concentration. DPC solution,
4 104 M; AKS solution, 4 109 g/mL; ﬂow rate, 2.0 mL/min.
Fig. 4 The effect of the DPC concentration. Luminol solution,
1 107 M; AKS solution, 4 109 g/mL; ﬂow rate, 2.0 mL/min.
Fig. 5 The effect of medium pH of luminol solution. Luminol
solution, 1 107 M; DPC solution, 4 104 M; AKS solution,
4 109 g/mL; ﬂow rate, 2.0 mL/min.
An FIA-CL method for the determination of amikacin sulfate by using diperiodatocuprate 363(0.1 M) was added to the luminol solutions to offer different
pH of CL system. The effects of pH (8–12) medium were
investigated. Fig. 5 shows that the optimal pH of the reaction
was 9.0. For obtaining the highest sensitivity and accuracy, a
pH 9.0 of luminol solution (KOH solution) was selected as the
optimum.
3.3. The analytical characteristics of the FI-CL method
Under the optimal experimental conditions, the calibration
graph of change of CL intensity, DI, against AKS concentra-
tion, was measured. There was a biphasic linear relationship
between the change in the CL intensity and the AKS concen-
tration over the range of 4.0 109 g/mL–4.0 107 g/mL and
4.0 107 g/mL–4.0 106 g/mL. The regression equation and
correlation coefﬁcients are listed in Table 1. The detection limit
was 1.2 109 g/mL (3s) and the relative standard deviation
was 2.3% for 8.0 109 g/mL AKS (n¼9).
3.4. Effects of coexisting foreign species
In order to apply the proposed method to determine AKS in a
practical sample, the effects of some possibly coexisting
foreign inorganic ions and organic compounds were examined.The effects of foreign substances were tested by analyzing a
standard solution of AKS (8 109 g/mL) to which increasing
amounts of interfering substances were added. The tolerable
concentration ratios with respect to 8 109 g/mL AKS at an
interference level of 5 % were over 1000 for Kþ, Naþ, Ca2þ,
Mg2þ, Cu2þ, Cuþ, Al3þ, Cd2þ, NH4
þ, Cl, Br, C2O4
2, NO3
,
SO4
2, IO3
, SeO3
2 and F; 500 for Fe2þ and Fe3þ; 200 for
amylum, urea and lactate; 100 for citrate; 10 for lactose,
ascorbic acid and lincomycin; 5 for glucose, Mn2þ and uric
acid; and 2 for sucrose. The interference of protein in human
serum could be ignored by ultra-ﬁltering the sample of human
serum. So the present method could be directly applied for the
determination of AKS in human serum.3.5. Analytical applications of the present FIA-CL method
The proposed method was applied to the determination of
AKS in human serum. Blank serum sample (2 mL) was
collected and transferred to a centrifugal ﬁlter unit and then
centrifuged at 10,000 rpm for 10 min at 4 1C. Then 1 mL
ﬁltrate was transferred to a 100 mL volumetric ﬂask and
diluted to the mark with doubly distilled water. The blank
serum was injected into the CL system, and the blank signal
was recorded. The amount of AKS in human serum and the
recovery obtained are shown in Table 2.3.6. Mechanism of the CL reaction
The electrochemical oxidation process is helpful in explaining
the oxidant characteristics of DPC. We had studied electro-
chemical behavior of the copper (II) metal chelate in strong
alkaline solution, which contained copper (II) and metaper-
iodate anion. The detailed description of the electrochemical
behavior had been reported in our previous study [31].
The obvious oxidation peak was observed at 0.42 V. The
results indicated that copper (II) could be oxidated into copper
(III), which was stable by chelation with polydentate ligands
(IO4
). Although the oxidative ability of copper (III) metal
chelate was weaker than that of other oxidants (such as
KMnO4, Ce(IV)), its peculiar oxidation can also make
the luminol-based CL reaction occur at a relative lower
Table 1 The analytical characteristics of the FI-CL method.
Range of AKS concentration (g/mL) Regression equation Correlation coefﬁcient
4.0 109–4.0 107 DI¼14.841caþ20.107 0.9978
4.0 107–4.0 106 DI ¼6.444caþ246.10 0.9970
aConcentration in ng/mL.
Table 2 Results of recovery tests of AKS in human serum.
Sample AKS in samplea (109 g/mL) Added (109 g/mL) Total founda (109 g/mL) Recovery ( %) RSD (%, n¼3)
No.1 4.87 1.00 5.92 105.0 0.8
3.00 7.78 97.0 0.6
5.00 9.98 102.2 1.2
No.2 5.23 4.00 9.48 106.3 2.5
6.00 11.42 98.8 3.1
8.00 13.57 103.2 2.6
No.3 10.53 6.00 16.62 101.5 1.6
10.00 20.46 99.3 2.1
14.00 24.72 101.4 3.5
aAverage value of the measure (n¼3).
Fig. 6 CL spectrum of the luminol-DPC-licomycin system. DPC,
1.0  104 M; luminol, 1 104 M; AKS, 2.0  104 g/mL; 1,
in the absence of AKS; 2, in the presence of AKS.
Y.-F. Hu et al.364concentration (107 M). In the oxidant reaction of DPC
participation, the cuprous complex was regarded as the ﬁnal
product because the electron transfer process was a single
electron process.
The CL spectrum of the luminol-DPC system is shown in
Fig. 6. The ﬂuorescence emission shows an obvious peak at
430 nm when the luminol was mixed with DPC. The obvious
intensive peak appeared at the same wavelength when AKS
was joined into the luminol-DPC system. It suggested that a
reaction between DPC and luminol occurred and the forma-
tion of intermediate states (exited Aminophthalate) was withan emission maximum at 425 nm. The CL intensity can be
enhanced in the presence of AKS.
Previous studies on oxidation of L-leucine and threonine by
Cu (III) [26,28] suggest that formation of [Cu(H3IO6)2(OH)2]
3 is
the reactive species of water-soluble Cu (III) periodate complex in
alkaline medium. From the oxidant reaction of L-leucine [26] and
isoniazid [32] by DPC, it is not difﬁcult to speculate the
mechanism of luminol-based CL reaction for the similar char-
acteristics of hydrazide in structure. The mechanism could suffer
from a free radical intervention. The CL reaction mechanism of
DPC-luminol is proposed in Fig. 7. Fortunately, the CL intensity
of DPC-luminol could be enhanced by AKS.4. Conclusion
In this work, a novel and sensitive CL method for the direct
determination of AKS in serum was developed. It was based
on the sensitization of AKS on the oxidant reaction of luminol
and DPC. Compared with other oxidants such as H2O2,
K3Fe(CN)6, KMnO4 and KIO4, DPC has been proved to be
a weaker oxidant. However, use of DPC enables the oxidant
reaction of luminol to occur at a lower concentration. It
makes the CL reaction more selective. Combined with ﬂow
injection technique, an attractive FIA-CL method has been
developed for its higher sensitivity, lower detection limit and
well reproducibility. The detection limit of AKS was at the
nanogram level. Recovery tests showed that the DPC-luminol
CL method was successfully applied in the determination of
AKS in serum without any pretreatment. It indicates that the
Fig. 7 One reaction mechanism suggested for the CL reaction between DPC and luminol.
An FIA-CL method for the determination of amikacin sulfate by using diperiodatocuprate 365Cu (III)-based CL method is a promising reagent. Moreover,
Cu (III) can broaden the application of CL method in further
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